Too many older Australians are missing out on recommended vaccinations for COVID, flu, shingles and pneumococcal that can protect them from serious illness, hospitalisation and even death.
In this Product Explainer, Geriatrician A/Prof Michael Woodward AM provides an update on the recombinant (ie non-live) herpes zoster vaccine and inclusion in the National Immunisation Program.
In this Product Explainer, Rhinologist Prof Richard Harvey explains the role of olopatadine hydrochloride and mometasone furoate combination nasal spray in the treatment of symptoms associated with allergic rhinitis and rhinoconjunctivitis in patients 6 years of age and older (5 mins).
In this Product Explainer, Rhinologist and Skull Base Surgeon A/Prof Raewyn Campbell explains the role of azelastine hydrochloride and fluticasone propionate nasal spray in the management of seasonal allergic rhinitis (5 mins).
In this Product Explainer, Paediatric Immunologist and Allergist Dr Brynn Wainstein provides an update on the management of anaphylaxis, including an overview of the guidelines, action plan and prescribing information for the EpiPen® adrenaline injector device (5 mins).
Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA
Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.